Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia

被引：0
|
作者：
Siami, K [1 ]
Awagu, S [1 ]
Cooper, DG [1 ]
Thomas, DA [1 ]
Huh, Y [1 ]
Jones, D [1 ]
Chen, W [1 ]
Jorgensen, JL [1 ]
机构：
[1] UTMDACC, Houston, TX USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1143
引用
收藏
页码：246A / 247A
页数：2
相关论文
共 50 条
  • [21] Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
    B Denys
    A J van der Sluijs-Gelling
    C Homburg
    C E van der Schoot
    V de Haas
    J Philippé
    R Pieters
    J J M van Dongen
    V H J van der Velden
    Leukemia, 2013, 27 : 635 - 641
  • [22] Minimal Residual Disease in Pediatric Precursor-B Acute Lymphoblastic Leukemia
    Naithani, Rahul
    INDIAN PEDIATRICS, 2016, 53 (12) : 1063 - 1064
  • [23] Overexpression of CD49f in Precursor B-cell Acute Lymphoblastic Leukemia: Potential Usefulness in Minimal Residual Disease Detection
    DiGiuseppe, Joseph A.
    Fuller, Sheila G.
    Borowitz, Michael J.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (02) : 150 - 155
  • [24] Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection
    Theunissen, Prisca M. J.
    Sedek, Lukasz
    De Haas, Valerie
    Szczepanski, Tomasz
    Van Der Sluijs, Alita
    Mejstrikova, Ester
    Novakova, Michaela
    Kalina, Tomas
    Lecrevisse, Quentin
    Orfao, Alberto
    Lankester, Arjan C.
    van Dongen, Jacques J. M.
    Van Der Velden, Vincent H. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (02) : 257 - 266
  • [25] Overexpression of CD49f in Precursor B-Cell Acute Lymphoblastic Leukemia: Efficiency of Minimal Residual Disease (MRD) Detection by Flow Cytometric Immunophenotyping Compared with Commonly Used Markers
    Shinoda-Matsuoka, H.
    DiGiuseppe, J. A.
    LABORATORY INVESTIGATION, 2009, 89 : 388A - 388A
  • [26] Overexpression of CD49f in Precursor B-Cell Acute Lymphoblastic Leukemia: Efficiency of Minimal Residual Disease (MRD) Detection by Flow Cytometric Immunophenotyping Compared with Commonly Used Markers
    Shinoda-Matsuoka, H.
    DiGiuseppe, J. A.
    MODERN PATHOLOGY, 2009, 22 : 388A - 388A
  • [27] FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
    Jen, Emily Y.
    Xu, Qing
    Schetter, Aaron
    Przepiorka, Donna
    Shen, Yuan Li
    Roscoe, Donna
    Sridhara, Rajeshwari
    Deisseroth, Albert
    Philip, Reena
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2019, 25 (02) : 473 - 477
  • [28] ABSOULT LYMPHOCYTE COUNT IS ASSCOCIATED WITH MINIMAL RESIDUAL DISEASE LEVEL IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Feng, J.
    Shen, H.
    Tang, Y.
    Song, H.
    Yang, S.
    Shi, S.
    Xu, W.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 69 - 70
  • [29] Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia
    Shen, Hong-Qiang
    Feng, Jian-Hua
    Tang, Yong-Min
    Song, Hua
    Yang, Shi-Long
    Shi, Shu-Wen
    Xu, Wei-Qun
    LEUKEMIA RESEARCH, 2013, 37 (06) : 671 - 674
  • [30] Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
    Mikhailova, Ekaterina
    Illarionova, Olga
    Komkov, Alexander
    Zerkalenkova, Elena
    Mamedov, Ilgar
    Shelikhova, Larisa
    Olshanskaya, Yulia
    Miakova, Natalia
    Novichkova, Galina
    Karachunskiy, Alexander
    Maschan, Michael
    Popov, Alexander
    CANCERS, 2022, 14 (21)
12345